Health
Orphan Drug Exemptions Face Scrutiny
A new analysis challenges the validity of a controversial provision in federal law that exempts orphan drugs from Medicare pricing negotiations, raising questions about its wisdom.
Coverage timeline — 1 article
STAT News
A new analysis questions the wisdom of a controversial provision in federal law that exempts so-called orphan drugs from Medicare pricing negotiations.
2026-08-04 12:05 UTC